Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Very positive. Challenging but fair. Opportunity to grow.
O que faz você mais feliz no trabalho?
The opportunity to save and extend life.
O que você mais gosta nos lideres?
Communication. Confidence. Strategic. Flexible. Resilient.
Quais são algumas das melhores coisas da sua equipe?
The team works well together and are likable.
Qual é a melhor parte das suas compensações?
Equity. Salary. Ignite Points. Car.
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Belief we are helping patients.
Other Employee Reviews for Karyopharm Therapeutics
×